Global Drug-Resistant Tuberculosis Treatment Market Growth (Status and Outlook) 2022-2028

Code: RW00014681224
LP Information
Jul-2022
Life Sciences
110 Pages

As the global economy mends, the 2021 growth of Drug-Resistant Tuberculosis Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Drug-Resistant Tuberculosis Treatment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Drug-Resistant Tuberculosis Treatment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Drug-Resistant Tuberculosis Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Drug-Resistant Tuberculosis Treatment market, reaching US$ million by the year 2028. As for the Europe Drug-Resistant Tuberculosis Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Drug-Resistant Tuberculosis Treatment players cover Sanofi, Novartis AG, Endo International plc, and CMP Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug-Resistant Tuberculosis Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
First-Line Anti-TB Drugs
Second-Line Anti-TB Drugs
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sanofi
Novartis AG
Endo International plc
CMP Pharma
STI Pharma LLC
Akorn Incorporated
Lupin
Johnson & Johnson Services Inc.
Macleods Pharmaceuticals Ltd
Pfizer Inc
Hikma Pharmaceuticals PLC
Lannett
Mylan N.V.
Teva Pharmaceutical Industries Ltd
Fresenius Kabi AG

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug-Resistant Tuberculosis Treatment Market Size 2017-2028
2.1.2 Drug-Resistant Tuberculosis Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Drug-Resistant Tuberculosis Treatment Segment by Type
2.2.1 First-Line Anti-TB Drugs
2.2.2 Second-Line Anti-TB Drugs
2.2.3 Others
2.3 Drug-Resistant Tuberculosis Treatment Market Size by Type
2.3.1 Drug-Resistant Tuberculosis Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type (2017-2022)
2.4 Drug-Resistant Tuberculosis Treatment Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Online Pharmacy
2.4.3 Retail Pharmacy
2.4.4 Others
2.5 Drug-Resistant Tuberculosis Treatment Market Size by Application
2.5.1 Drug-Resistant Tuberculosis Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application (2017-2022)
3 Drug-Resistant Tuberculosis Treatment Market Size by Player
3.1 Drug-Resistant Tuberculosis Treatment Market Size Market Share by Players
3.1.1 Global Drug-Resistant Tuberculosis Treatment Revenue by Players (2020-2022)
3.1.2 Global Drug-Resistant Tuberculosis Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Drug-Resistant Tuberculosis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug-Resistant Tuberculosis Treatment by Regions
4.1 Drug-Resistant Tuberculosis Treatment Market Size by Regions (2017-2022)
4.2 Americas Drug-Resistant Tuberculosis Treatment Market Size Growth (2017-2022)
4.3 APAC Drug-Resistant Tuberculosis Treatment Market Size Growth (2017-2022)
4.4 Europe Drug-Resistant Tuberculosis Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas Drug-Resistant Tuberculosis Treatment Market Size by Country (2017-2022)
5.2 Americas Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022)
5.3 Americas Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-Resistant Tuberculosis Treatment Market Size by Region (2017-2022)
6.2 APAC Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022)
6.3 APAC Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug-Resistant Tuberculosis Treatment by Country (2017-2022)
7.2 Europe Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022)
7.3 Europe Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug-Resistant Tuberculosis Treatment by Region (2017-2022)
8.2 Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug-Resistant Tuberculosis Treatment Market Forecast
10.1 Global Drug-Resistant Tuberculosis Treatment Forecast by Regions (2023-2028)
10.1.1 Global Drug-Resistant Tuberculosis Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Drug-Resistant Tuberculosis Treatment Forecast
10.1.3 APAC Drug-Resistant Tuberculosis Treatment Forecast
10.1.4 Europe Drug-Resistant Tuberculosis Treatment Forecast
10.1.5 Middle East & Africa Drug-Resistant Tuberculosis Treatment Forecast
10.2 Americas Drug-Resistant Tuberculosis Treatment Forecast by Country (2023-2028)
10.2.1 United States Drug-Resistant Tuberculosis Treatment Market Forecast
10.2.2 Canada Drug-Resistant Tuberculosis Treatment Market Forecast
10.2.3 Mexico Drug-Resistant Tuberculosis Treatment Market Forecast
10.2.4 Brazil Drug-Resistant Tuberculosis Treatment Market Forecast
10.3 APAC Drug-Resistant Tuberculosis Treatment Forecast by Region (2023-2028)
10.3.1 China Drug-Resistant Tuberculosis Treatment Market Forecast
10.3.2 Japan Drug-Resistant Tuberculosis Treatment Market Forecast
10.3.3 Korea Drug-Resistant Tuberculosis Treatment Market Forecast
10.3.4 Southeast Asia Drug-Resistant Tuberculosis Treatment Market Forecast
10.3.5 India Drug-Resistant Tuberculosis Treatment Market Forecast
10.3.6 Australia Drug-Resistant Tuberculosis Treatment Market Forecast
10.4 Europe Drug-Resistant Tuberculosis Treatment Forecast by Country (2023-2028)
10.4.1 Germany Drug-Resistant Tuberculosis Treatment Market Forecast
10.4.2 France Drug-Resistant Tuberculosis Treatment Market Forecast
10.4.3 UK Drug-Resistant Tuberculosis Treatment Market Forecast
10.4.4 Italy Drug-Resistant Tuberculosis Treatment Market Forecast
10.4.5 Russia Drug-Resistant Tuberculosis Treatment Market Forecast
10.5 Middle East & Africa Drug-Resistant Tuberculosis Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Drug-Resistant Tuberculosis Treatment Market Forecast
10.5.2 South Africa Drug-Resistant Tuberculosis Treatment Market Forecast
10.5.3 Israel Drug-Resistant Tuberculosis Treatment Market Forecast
10.5.4 Turkey Drug-Resistant Tuberculosis Treatment Market Forecast
10.5.5 GCC Countries Drug-Resistant Tuberculosis Treatment Market Forecast
10.6 Global Drug-Resistant Tuberculosis Treatment Forecast by Type (2023-2028)
10.7 Global Drug-Resistant Tuberculosis Treatment Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Drug-Resistant Tuberculosis Treatment Product Offered
11.1.3 Sanofi Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Information
11.2.2 Novartis AG Drug-Resistant Tuberculosis Treatment Product Offered
11.2.3 Novartis AG Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis AG Main Business Overview
11.2.5 Novartis AG Latest Developments
11.3 Endo International plc
11.3.1 Endo International plc Company Information
11.3.2 Endo International plc Drug-Resistant Tuberculosis Treatment Product Offered
11.3.3 Endo International plc Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Endo International plc Main Business Overview
11.3.5 Endo International plc Latest Developments
11.4 CMP Pharma
11.4.1 CMP Pharma Company Information
11.4.2 CMP Pharma Drug-Resistant Tuberculosis Treatment Product Offered
11.4.3 CMP Pharma Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 CMP Pharma Main Business Overview
11.4.5 CMP Pharma Latest Developments
11.5 STI Pharma LLC
11.5.1 STI Pharma LLC Company Information
11.5.2 STI Pharma LLC Drug-Resistant Tuberculosis Treatment Product Offered
11.5.3 STI Pharma LLC Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 STI Pharma LLC Main Business Overview
11.5.5 STI Pharma LLC Latest Developments
11.6 Akorn Incorporated
11.6.1 Akorn Incorporated Company Information
11.6.2 Akorn Incorporated Drug-Resistant Tuberculosis Treatment Product Offered
11.6.3 Akorn Incorporated Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Akorn Incorporated Main Business Overview
11.6.5 Akorn Incorporated Latest Developments
11.7 Lupin
11.7.1 Lupin Company Information
11.7.2 Lupin Drug-Resistant Tuberculosis Treatment Product Offered
11.7.3 Lupin Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Lupin Main Business Overview
11.7.5 Lupin Latest Developments
11.8 Johnson & Johnson Services Inc.
11.8.1 Johnson & Johnson Services Inc. Company Information
11.8.2 Johnson & Johnson Services Inc. Drug-Resistant Tuberculosis Treatment Product Offered
11.8.3 Johnson & Johnson Services Inc. Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Johnson & Johnson Services Inc. Main Business Overview
11.8.5 Johnson & Johnson Services Inc. Latest Developments
11.9 Macleods Pharmaceuticals Ltd
11.9.1 Macleods Pharmaceuticals Ltd Company Information
11.9.2 Macleods Pharmaceuticals Ltd Drug-Resistant Tuberculosis Treatment Product Offered
11.9.3 Macleods Pharmaceuticals Ltd Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Macleods Pharmaceuticals Ltd Main Business Overview
11.9.5 Macleods Pharmaceuticals Ltd Latest Developments
11.10 Pfizer Inc
11.10.1 Pfizer Inc Company Information
11.10.2 Pfizer Inc Drug-Resistant Tuberculosis Treatment Product Offered
11.10.3 Pfizer Inc Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Pfizer Inc Main Business Overview
11.10.5 Pfizer Inc Latest Developments
11.11 Hikma Pharmaceuticals PLC
11.11.1 Hikma Pharmaceuticals PLC Company Information
11.11.2 Hikma Pharmaceuticals PLC Drug-Resistant Tuberculosis Treatment Product Offered
11.11.3 Hikma Pharmaceuticals PLC Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Hikma Pharmaceuticals PLC Main Business Overview
11.11.5 Hikma Pharmaceuticals PLC Latest Developments
11.12 Lannett
11.12.1 Lannett Company Information
11.12.2 Lannett Drug-Resistant Tuberculosis Treatment Product Offered
11.12.3 Lannett Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Lannett Main Business Overview
11.12.5 Lannett Latest Developments
11.13 Mylan N.V.
11.13.1 Mylan N.V. Company Information
11.13.2 Mylan N.V. Drug-Resistant Tuberculosis Treatment Product Offered
11.13.3 Mylan N.V. Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Mylan N.V. Main Business Overview
11.13.5 Mylan N.V. Latest Developments
11.14 Teva Pharmaceutical Industries Ltd
11.14.1 Teva Pharmaceutical Industries Ltd Company Information
11.14.2 Teva Pharmaceutical Industries Ltd Drug-Resistant Tuberculosis Treatment Product Offered
11.14.3 Teva Pharmaceutical Industries Ltd Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Teva Pharmaceutical Industries Ltd Main Business Overview
11.14.5 Teva Pharmaceutical Industries Ltd Latest Developments
11.15 Fresenius Kabi AG
11.15.1 Fresenius Kabi AG Company Information
11.15.2 Fresenius Kabi AG Drug-Resistant Tuberculosis Treatment Product Offered
11.15.3 Fresenius Kabi AG Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Fresenius Kabi AG Main Business Overview
11.15.5 Fresenius Kabi AG Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Drug-Resistant Tuberculosis Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of First-Line Anti-TB Drugs
Table 3. Major Players of Second-Line Anti-TB Drugs
Table 4. Major Players of Others
Table 5. Drug-Resistant Tuberculosis Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type (2017-2022)
Table 8. Drug-Resistant Tuberculosis Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application (2017-2022)
Table 11. Global Drug-Resistant Tuberculosis Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Drug-Resistant Tuberculosis Treatment Revenue Market Share by Player (2020-2022)
Table 13. Drug-Resistant Tuberculosis Treatment Key Players Head office and Products Offered
Table 14. Drug-Resistant Tuberculosis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Drug-Resistant Tuberculosis Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Regions (2017-2022)
Table 19. Americas Drug-Resistant Tuberculosis Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Drug-Resistant Tuberculosis Treatment Market Size Market Share by Country (2017-2022)
Table 21. Americas Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type (2017-2022)
Table 23. Americas Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application (2017-2022)
Table 25. APAC Drug-Resistant Tuberculosis Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Drug-Resistant Tuberculosis Treatment Market Size Market Share by Region (2017-2022)
Table 27. APAC Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type (2017-2022)
Table 29. APAC Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application (2017-2022)
Table 31. Europe Drug-Resistant Tuberculosis Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Drug-Resistant Tuberculosis Treatment Market Size Market Share by Country (2017-2022)
Table 33. Europe Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type (2017-2022)
Table 35. Europe Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Drug-Resistant Tuberculosis Treatment
Table 44. Key Market Challenges & Risks of Drug-Resistant Tuberculosis Treatment
Table 45. Key Industry Trends of Drug-Resistant Tuberculosis Treatment
Table 46. Global Drug-Resistant Tuberculosis Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Drug-Resistant Tuberculosis Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Drug-Resistant Tuberculosis Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 52. Sanofi Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors
Table 53. Sanofi Drug-Resistant Tuberculosis Treatment Product Offered
Table 54. Sanofi Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Sanofi Main Business
Table 56. Sanofi Latest Developments
Table 57. Novartis AG Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors
Table 58. Novartis AG Drug-Resistant Tuberculosis Treatment Product Offered
Table 59. Novartis AG Main Business
Table 60. Novartis AG Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Novartis AG Latest Developments
Table 62. Endo International plc Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors
Table 63. Endo International plc Drug-Resistant Tuberculosis Treatment Product Offered
Table 64. Endo International plc Main Business
Table 65. Endo International plc Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Endo International plc Latest Developments
Table 67. CMP Pharma Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors
Table 68. CMP Pharma Drug-Resistant Tuberculosis Treatment Product Offered
Table 69. CMP Pharma Main Business
Table 70. CMP Pharma Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. CMP Pharma Latest Developments
Table 72. STI Pharma LLC Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors
Table 73. STI Pharma LLC Drug-Resistant Tuberculosis Treatment Product Offered
Table 74. STI Pharma LLC Main Business
Table 75. STI Pharma LLC Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. STI Pharma LLC Latest Developments
Table 77. Akorn Incorporated Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors
Table 78. Akorn Incorporated Drug-Resistant Tuberculosis Treatment Product Offered
Table 79. Akorn Incorporated Main Business
Table 80. Akorn Incorporated Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Akorn Incorporated Latest Developments
Table 82. Lupin Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors
Table 83. Lupin Drug-Resistant Tuberculosis Treatment Product Offered
Table 84. Lupin Main Business
Table 85. Lupin Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Lupin Latest Developments
Table 87. Johnson & Johnson Services Inc. Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors
Table 88. Johnson & Johnson Services Inc. Drug-Resistant Tuberculosis Treatment Product Offered
Table 89. Johnson & Johnson Services Inc. Main Business
Table 90. Johnson & Johnson Services Inc. Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Johnson & Johnson Services Inc. Latest Developments
Table 92. Macleods Pharmaceuticals Ltd Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors
Table 93. Macleods Pharmaceuticals Ltd Drug-Resistant Tuberculosis Treatment Product Offered
Table 94. Macleods Pharmaceuticals Ltd Main Business
Table 95. Macleods Pharmaceuticals Ltd Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Macleods Pharmaceuticals Ltd Latest Developments
Table 97. Pfizer Inc Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors
Table 98. Pfizer Inc Drug-Resistant Tuberculosis Treatment Product Offered
Table 99. Pfizer Inc Main Business
Table 100. Pfizer Inc Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Pfizer Inc Latest Developments
Table 102. Hikma Pharmaceuticals PLC Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors
Table 103. Hikma Pharmaceuticals PLC Drug-Resistant Tuberculosis Treatment Product Offered
Table 104. Hikma Pharmaceuticals PLC Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Hikma Pharmaceuticals PLC Main Business
Table 106. Hikma Pharmaceuticals PLC Latest Developments
Table 107. Lannett Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors
Table 108. Lannett Drug-Resistant Tuberculosis Treatment Product Offered
Table 109. Lannett Main Business
Table 110. Lannett Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Lannett Latest Developments
Table 112. Mylan N.V. Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors
Table 113. Mylan N.V. Drug-Resistant Tuberculosis Treatment Product Offered
Table 114. Mylan N.V. Main Business
Table 115. Mylan N.V. Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Mylan N.V. Latest Developments
Table 117. Teva Pharmaceutical Industries Ltd Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors
Table 118. Teva Pharmaceutical Industries Ltd Drug-Resistant Tuberculosis Treatment Product Offered
Table 119. Teva Pharmaceutical Industries Ltd Main Business
Table 120. Teva Pharmaceutical Industries Ltd Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Teva Pharmaceutical Industries Ltd Latest Developments
Table 122. Fresenius Kabi AG Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors
Table 123. Fresenius Kabi AG Drug-Resistant Tuberculosis Treatment Product Offered
Table 124. Fresenius Kabi AG Main Business
Table 125. Fresenius Kabi AG Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. Fresenius Kabi AG Latest Developments
List of Figures
Figure 1. Drug-Resistant Tuberculosis Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug-Resistant Tuberculosis Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type in 2021
Figure 7. Drug-Resistant Tuberculosis Treatment in Hospital Pharmacy
Figure 8. Global Drug-Resistant Tuberculosis Treatment Market: Hospital Pharmacy (2017-2022) & ($ Millions)
Figure 9. Drug-Resistant Tuberculosis Treatment in Online Pharmacy
Figure 10. Global Drug-Resistant Tuberculosis Treatment Market: Online Pharmacy (2017-2022) & ($ Millions)
Figure 11. Drug-Resistant Tuberculosis Treatment in Retail Pharmacy
Figure 12. Global Drug-Resistant Tuberculosis Treatment Market: Retail Pharmacy (2017-2022) & ($ Millions)
Figure 13. Drug-Resistant Tuberculosis Treatment in Others
Figure 14. Global Drug-Resistant Tuberculosis Treatment Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application in 2021
Figure 16. Global Drug-Resistant Tuberculosis Treatment Revenue Market Share by Player in 2021
Figure 17. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Drug-Resistant Tuberculosis Treatment Market Size 2017-2022 ($ Millions)
Figure 19. APAC Drug-Resistant Tuberculosis Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Europe Drug-Resistant Tuberculosis Treatment Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size 2017-2022 ($ Millions)
Figure 22. Americas Drug-Resistant Tuberculosis Treatment Value Market Share by Country in 2021
Figure 23. Americas Drug-Resistant Tuberculosis Treatment Consumption Market Share by Type in 2021
Figure 24. Americas Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application in 2021
Figure 25. United States Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Drug-Resistant Tuberculosis Treatment Market Size Market Share by Region in 2021
Figure 30. APAC Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application in 2021
Figure 31. China Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Drug-Resistant Tuberculosis Treatment Market Size Market Share by Country in 2021
Figure 38. Europe Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type in 2021
Figure 39. Europe Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application in 2021
Figure 40. Germany Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application in 2021
Figure 48. Egypt Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 54. APAC Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 55. Europe Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 57. United States Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Canada Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 61. China Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Japan Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 63. Korea Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 65. India Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 66. Australia Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 67. Germany Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 68. France Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 69. UK Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Italy Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Russia Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 72. Spain Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 75. Israel Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE